User profiles for Shaman Jhanji
 | Shaman JhanjiRoyal Marsden & Institute of Cancer Research Verified email at rmh.nhs.uk Cited by 12396 |
[HTML][HTML] Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
Background During the COVID-19 lockdown, referrals via the 2-week-wait urgent pathway
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …
for suspected cancer in England, UK, are reported to have decreased by up to 84%. We …
[HTML][HTML] Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic
Background Cancer diagnostics and surgery have been disrupted by the response of health
care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of …
care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of …
Long-term Survival for Patients Undergoing Volatile versus IV Anesthesia for Cancer Surgery: A Retrospective Analysis
TJ Wigmore, K Mohammed, S Jhanji - Anesthesiology, 2016 - pubs.asahq.org
Background Surgical resection remains the best option for long-term survival in many solid
tumors. Surgery can, however, lead to tumor cell release into the circulation. Data have …
tumors. Surgery can, however, lead to tumor cell release into the circulation. Data have …
[HTML][HTML] Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune monitoring
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
(CAPTURE) ( NCT03226886 ) is a prospective cohort study of COVID-19 immunity in …
Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study
…, N MacDonald, ML Pakats, K Greaves, S Jhanji… - The Lancet, 2018 - thelancet.com
Background Functional capacity is an important component of risk assessment for major
surgery. Doctors' clinical subjective assessment of patients' functional capacity has uncertain …
surgery. Doctors' clinical subjective assessment of patients' functional capacity has uncertain …
The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock
S Jhanji, S Stirling, N Patel, CJ Hinds… - Critical care …, 2009 - journals.lww.com
Objective: To investigate the effect of escalating doses of norepinephrine, aimed at achieving
incremental increases in mean arterial pressure (MAP), on microvascular flow and tissue …
incremental increases in mean arterial pressure (MAP), on microvascular flow and tissue …
Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications
Objective To evaluate the relationship between global oxygen delivery (DO 2 I), microvascular
flow and tissue oxygenation in patients who did and did not develop complications …
flow and tissue oxygenation in patients who did and did not develop complications …
[HTML][HTML] Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial
S Jhanji, A Vivian-Smith, S Lucena-Amaro, D Watson… - Critical Care, 2010 - Springer
Introduction Post-operative outcomes may be improved by the use of flow related end-points
for intra-venous fluid and/or low dose inotropic therapy. The mechanisms underlying this …
for intra-venous fluid and/or low dose inotropic therapy. The mechanisms underlying this …
[HTML][HTML] Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer
…, RL Shea, G Gardner, D Murray, N Yousaf, S Jhanji… - The Lancet, 2022 - thelancet.com
Patients with cancer are at greater risk of severe COVID-19 and have been prioritised for
COVID-19 vaccination globally. We previously showed that following two doses of COVID-19 …
COVID-19 vaccination globally. We previously showed that following two doses of COVID-19 …
[PDF][PDF] Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Patients with cancer are at higher risk of severe COVID-19 (Grivas et al., 2021; Kuderer et al.,
2020), and they are currently prioritized globally for a third COVID-19 vaccine dose. …
2020), and they are currently prioritized globally for a third COVID-19 vaccine dose. …
